So they solved the problem of paying one million dollars with an already developed drug by making a new drug that costs... $2.125 million.

"Novartis' Zolgensma, a one-time gene therapy for spinal muscular atrophy tops the list with a price tag of $2.125 million."

https://www.biospace.com/article/gene-therapy-zolgensma-tops...